Walleye Capital’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-48,500
Closed -$1.3M 5105
2025
Q3
$1.3M Sell
48,500
-10,500
-18% -$250K ﹤0.01% 1891
2025
Q2
$990K Buy
59,000
+42,900
+266% +$756K ﹤0.01% 2062
2025
Q1
$284K Buy
16,100
+13,500
+519% +$271K ﹤0.01% 2990
2024
Q4
$63.2K Sell
2,600
-6,700
-72% -$191K ﹤0.01% 4296
2024
Q3
$345K Sell
9,300
-43,900
-83% -$1.64M ﹤0.01% 3622
2024
Q2
$2.53M Buy
53,200
+42,700
+407% +$1.87M ﹤0.01% 1881
2024
Q1
$402K Buy
10,500
+6,800
+184% +$221K ﹤0.01% 3392
2023
Q4
$115K Sell
3,700
-6,600
-64% -$237K ﹤0.01% 3986
2023
Q3
$414K Sell
10,300
-6,300
-38% -$295K ﹤0.01% 2960
2023
Q2
$873K Buy
+16,600
New +$1.01M ﹤0.01% 1965
2022
Q4
Sell
-13,800
Closed -$974K 3612
2022
Q3
$974K Buy
+13,800
New +$1.18M 0.02% 991

Other funds holding STAA

Walleye Capital's STAA Position: Q4 2025 in Review

Walleye Capital sold out of STAAR Surgical (STAA) in Q4 2025, closing a stake of 627 shares — an estimated $16.8K sold.

Walleye Capital first reported a position in STAA in Q3 2020 and held it in 15 quarters. The position peaked at $3.05M in Q4 2022. 201 funds tracked by Wall St. Rank hold STAA as of Q4 2025.

  • Walleye Capital reported no remaining STAAR Surgical position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 627 STAAR Surgical shares in Q4 2025, an estimated $16.8K.
  • Walleye Capital first reported a position in STAAR Surgical in Q3 2020 and held it in 15 quarters.
  • Walleye Capital's STAAR Surgical position peaked at $3.05M in Q4 2022.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.